Pregnancy outcomes in healthy nulliparas who developed hypertension

John C. Hauth, Marian G. Ewell, Richard J. Levine, Joy R. Esterlitz, Baha Sibai, Luis B. Curet, Patrick M. Catalano, Cynthia Morris

Research output: Contribution to journalArticle

272 Citations (Scopus)

Abstract

Objective: To determine maternal and perinatal outcomes in nulliparas with pregnancy-associated hypertension or preeclampsia.Methods: We conducted (and reported elsewhere) a randomized, double-masked, placebo-controlled trial calcium supplementation of 4589 healthy nulliparas assigned at 13-21 weeks' gestation. This well-defined and characterized data set provided an opportunity to detail more precisely adverse maternal, fetal, and newborn outcomes in women who developed hypertension among a prospective series of healthy nulliparas.Results: Of 4302 women observed to or beyond 20 weeks' gestation, 1073 (24.9%) developed mild or severe pregnancy-associated hypertension or preeclampsia. One hundred sixteen women of the 1073 with hypertension (10.8%) and 336 of the 3229 without hypertension (10.4%) were delivered before 37 weeks' gestation. Fetal and neonatal mortality were similar in those groups; however, selected maternal and newborn morbidities were significantly greater in women with hypertension. Significantly increased maternal morbidities included increased cesarean deliveries, abruptio placentae, and acute renal dysfunction; and significantly increased perinatal morbidities included respiratory distress syndrome, ventilatory support, and fetal growth restriction. Adverse outcomes were highest in women with severe pregnancy-associated hypertension or preeclampsia.Conclusion: Hypertension, especially severe hypertension, was associated with an appreciable increase in important maternal and perinatal morbidity but not perinatal mortality. Copyright (C) 2000 The American College of Obstetricians and Gynecologists.

Original languageEnglish (US)
Pages (from-to)24-28
Number of pages5
JournalObstetrics and Gynecology
Volume95
Issue number1
DOIs
StatePublished - Jan 2000

Fingerprint

Pregnancy Outcome
Hypertension
Pregnancy
Mothers
Pre-Eclampsia
Morbidity
Newborn Infant
Abruptio Placentae
Fetal Mortality
Perinatal Mortality
Infant Mortality
Fetal Development
Placebos
Calcium
Kidney

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Hauth, J. C., Ewell, M. G., Levine, R. J., Esterlitz, J. R., Sibai, B., Curet, L. B., ... Morris, C. (2000). Pregnancy outcomes in healthy nulliparas who developed hypertension. Obstetrics and Gynecology, 95(1), 24-28. https://doi.org/10.1016/S0029-7844(99)00462-7

Pregnancy outcomes in healthy nulliparas who developed hypertension. / Hauth, John C.; Ewell, Marian G.; Levine, Richard J.; Esterlitz, Joy R.; Sibai, Baha; Curet, Luis B.; Catalano, Patrick M.; Morris, Cynthia.

In: Obstetrics and Gynecology, Vol. 95, No. 1, 01.2000, p. 24-28.

Research output: Contribution to journalArticle

Hauth, JC, Ewell, MG, Levine, RJ, Esterlitz, JR, Sibai, B, Curet, LB, Catalano, PM & Morris, C 2000, 'Pregnancy outcomes in healthy nulliparas who developed hypertension', Obstetrics and Gynecology, vol. 95, no. 1, pp. 24-28. https://doi.org/10.1016/S0029-7844(99)00462-7
Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Obstetrics and Gynecology. 2000 Jan;95(1):24-28. https://doi.org/10.1016/S0029-7844(99)00462-7
Hauth, John C. ; Ewell, Marian G. ; Levine, Richard J. ; Esterlitz, Joy R. ; Sibai, Baha ; Curet, Luis B. ; Catalano, Patrick M. ; Morris, Cynthia. / Pregnancy outcomes in healthy nulliparas who developed hypertension. In: Obstetrics and Gynecology. 2000 ; Vol. 95, No. 1. pp. 24-28.
@article{e2972caede2a45149f7420d244b79b4d,
title = "Pregnancy outcomes in healthy nulliparas who developed hypertension",
abstract = "Objective: To determine maternal and perinatal outcomes in nulliparas with pregnancy-associated hypertension or preeclampsia.Methods: We conducted (and reported elsewhere) a randomized, double-masked, placebo-controlled trial calcium supplementation of 4589 healthy nulliparas assigned at 13-21 weeks' gestation. This well-defined and characterized data set provided an opportunity to detail more precisely adverse maternal, fetal, and newborn outcomes in women who developed hypertension among a prospective series of healthy nulliparas.Results: Of 4302 women observed to or beyond 20 weeks' gestation, 1073 (24.9{\%}) developed mild or severe pregnancy-associated hypertension or preeclampsia. One hundred sixteen women of the 1073 with hypertension (10.8{\%}) and 336 of the 3229 without hypertension (10.4{\%}) were delivered before 37 weeks' gestation. Fetal and neonatal mortality were similar in those groups; however, selected maternal and newborn morbidities were significantly greater in women with hypertension. Significantly increased maternal morbidities included increased cesarean deliveries, abruptio placentae, and acute renal dysfunction; and significantly increased perinatal morbidities included respiratory distress syndrome, ventilatory support, and fetal growth restriction. Adverse outcomes were highest in women with severe pregnancy-associated hypertension or preeclampsia.Conclusion: Hypertension, especially severe hypertension, was associated with an appreciable increase in important maternal and perinatal morbidity but not perinatal mortality. Copyright (C) 2000 The American College of Obstetricians and Gynecologists.",
author = "Hauth, {John C.} and Ewell, {Marian G.} and Levine, {Richard J.} and Esterlitz, {Joy R.} and Baha Sibai and Curet, {Luis B.} and Catalano, {Patrick M.} and Cynthia Morris",
year = "2000",
month = "1",
doi = "10.1016/S0029-7844(99)00462-7",
language = "English (US)",
volume = "95",
pages = "24--28",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Pregnancy outcomes in healthy nulliparas who developed hypertension

AU - Hauth, John C.

AU - Ewell, Marian G.

AU - Levine, Richard J.

AU - Esterlitz, Joy R.

AU - Sibai, Baha

AU - Curet, Luis B.

AU - Catalano, Patrick M.

AU - Morris, Cynthia

PY - 2000/1

Y1 - 2000/1

N2 - Objective: To determine maternal and perinatal outcomes in nulliparas with pregnancy-associated hypertension or preeclampsia.Methods: We conducted (and reported elsewhere) a randomized, double-masked, placebo-controlled trial calcium supplementation of 4589 healthy nulliparas assigned at 13-21 weeks' gestation. This well-defined and characterized data set provided an opportunity to detail more precisely adverse maternal, fetal, and newborn outcomes in women who developed hypertension among a prospective series of healthy nulliparas.Results: Of 4302 women observed to or beyond 20 weeks' gestation, 1073 (24.9%) developed mild or severe pregnancy-associated hypertension or preeclampsia. One hundred sixteen women of the 1073 with hypertension (10.8%) and 336 of the 3229 without hypertension (10.4%) were delivered before 37 weeks' gestation. Fetal and neonatal mortality were similar in those groups; however, selected maternal and newborn morbidities were significantly greater in women with hypertension. Significantly increased maternal morbidities included increased cesarean deliveries, abruptio placentae, and acute renal dysfunction; and significantly increased perinatal morbidities included respiratory distress syndrome, ventilatory support, and fetal growth restriction. Adverse outcomes were highest in women with severe pregnancy-associated hypertension or preeclampsia.Conclusion: Hypertension, especially severe hypertension, was associated with an appreciable increase in important maternal and perinatal morbidity but not perinatal mortality. Copyright (C) 2000 The American College of Obstetricians and Gynecologists.

AB - Objective: To determine maternal and perinatal outcomes in nulliparas with pregnancy-associated hypertension or preeclampsia.Methods: We conducted (and reported elsewhere) a randomized, double-masked, placebo-controlled trial calcium supplementation of 4589 healthy nulliparas assigned at 13-21 weeks' gestation. This well-defined and characterized data set provided an opportunity to detail more precisely adverse maternal, fetal, and newborn outcomes in women who developed hypertension among a prospective series of healthy nulliparas.Results: Of 4302 women observed to or beyond 20 weeks' gestation, 1073 (24.9%) developed mild or severe pregnancy-associated hypertension or preeclampsia. One hundred sixteen women of the 1073 with hypertension (10.8%) and 336 of the 3229 without hypertension (10.4%) were delivered before 37 weeks' gestation. Fetal and neonatal mortality were similar in those groups; however, selected maternal and newborn morbidities were significantly greater in women with hypertension. Significantly increased maternal morbidities included increased cesarean deliveries, abruptio placentae, and acute renal dysfunction; and significantly increased perinatal morbidities included respiratory distress syndrome, ventilatory support, and fetal growth restriction. Adverse outcomes were highest in women with severe pregnancy-associated hypertension or preeclampsia.Conclusion: Hypertension, especially severe hypertension, was associated with an appreciable increase in important maternal and perinatal morbidity but not perinatal mortality. Copyright (C) 2000 The American College of Obstetricians and Gynecologists.

UR - http://www.scopus.com/inward/record.url?scp=0033988705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033988705&partnerID=8YFLogxK

U2 - 10.1016/S0029-7844(99)00462-7

DO - 10.1016/S0029-7844(99)00462-7

M3 - Article

VL - 95

SP - 24

EP - 28

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 1

ER -